These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18464560)

  • 1. [Epidemiology of mycosis and pathogen susceptibility to antimycotics].
    Sidorenko SV
    Antibiot Khimioter; 2007; 52(4-5):3-11. PubMed ID: 18464560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance to antimycotics: role of calcineurin and protein kinases].
    Nikitin AV
    Antibiot Khimioter; 2009; 54(3-4):3-5. PubMed ID: 19711840
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?
    Hull CM; Purdy NJ; Moody SC
    Future Microbiol; 2014; 9(3):307-25. PubMed ID: 24762306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of antifungal resistance and its impact on clinical practice.
    Alcazar-Fuoli L; Mellado E
    Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How do fungal infections "escape" treatment? Resistance and resistance mechanisms].
    Morschhäuser J
    Pharm Unserer Zeit; 2003; 32(2):124-8. PubMed ID: 12677965
    [No Abstract]   [Full Text] [Related]  

  • 7. 42nd annual meeting of the German-Speaking Mycological Society (DMykG). Abstracts.
    Mycoses; 2008 Sep; 51(5):365-436. PubMed ID: 18783554
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology of antifungal susceptibility: Review of literature.
    Hadrich I; Ayadi A
    J Mycol Med; 2018 Sep; 28(3):574-584. PubMed ID: 29773435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteroresistance and fungi.
    Ferreira GF; Santos DA
    Mycoses; 2017 Sep; 60(9):562-568. PubMed ID: 28660647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive fungal infections: past achievements and challenges ahead.
    Arendrup MC
    Clin Microbiol Infect; 2009 Jul; 15(7):599-601. PubMed ID: 19673970
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifungal resistance in clinically significant fungi.
    Chowdhary A; Meis JF
    Fungal Genet Biol; 2020 Jun; 139():103369. PubMed ID: 32201127
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances].
    Cuenca-Estrella M
    Rev Esp Quimioter; 2010 Dec; 23(4):169-76. PubMed ID: 21191554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances and challenges in the treatment of invasive fungal infections.
    Shao PL; Huang LM; Hsueh PR
    Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review.
    Sun HY; Singh N
    Int J Antimicrob Agents; 2010 Mar; 35(3):211-8. PubMed ID: 20036518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the antimycotics sensitivity of certain fungi after the effect of hydrogen peroxide].
    Schönborn C; Ludewig R; Schuhmann P
    Dermatol Monatsschr; 1976 Aug; 162(8):669-74. PubMed ID: 971784
    [No Abstract]   [Full Text] [Related]  

  • 16. Changing epidemiology of systemic fungal infections.
    Richardson M; Lass-Flörl C
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Our 2014 approach to breakthrough invasive fungal infections.
    Maschmeyer G; Patterson TF
    Mycoses; 2014 Nov; 57(11):645-51. PubMed ID: 24963554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal drug resistance of pathogenic fungi.
    Kontoyiannis DP; Lewis RE
    Lancet; 2002 Mar; 359(9312):1135-44. PubMed ID: 11943280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside.
    Cuenca-Estrella M
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():54-9. PubMed ID: 24372680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance.
    Albataineh MT; Sutton DA; Fothergill AW; Wiederhold NP
    Infect Dis Clin North Am; 2016 Mar; 30(1):13-35. PubMed ID: 26739605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.